Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., Cooper, C.·2003·Arthritis & Rheumatism

DOI 10.1002/art.11283

Cited by (556)

Items 101–200 of 556

Long-term complications of past glucocorticoid use
Luciana Parente Costa Seguro, Cristina Rosário, Yehuda Shoenfeld · 2012 · Autoimmunity Reviews
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases
Frank Buttgereit, Andriko Palmowski, Milena Bond, Giovanni Adami, Christian Dejaco · 2024 · Nature Reviews Rheumatology
Glucocorticoid-induced osteoporosis: novel concepts and clinical implications
Lorenz Christian Hofbauer, Juliet Elizabeth Compston, Kenneth G. Saag, Martina Rauner, Elena A. Tsourdi · 2025 · The Lancet Diabetes & Endocrinology
Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy
Jennifer M Bell, Michael David Shields, Janet Watters, Alistair Hamilton, Timothy R. O. Beringer, Mark Elliott, Rosaline C. M. Quinlivan, Sandya Tirupathi, Bronagh Blackwood · 2017 · Cochrane Database of Systematic Reviews
Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
R. N. J. de Nijs · 2008 · PubMed
Bone status in glucocorticoid-treated men and women
Edward S. Leib, Renaud Winzenrieth · 2015 · Osteoporosis International
Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus
Nancy E. Lane · 2006 · Nature Clinical Practice Rheumatology
Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society
Anastasilakis, Athanasios D., Tsourdi, Elena, Makras, Polyzois, Polyzos, Stergios A., Meier, Christian, McCloskey, Eugene V., Pepe, Jessica, Zillikens, M. Carola · 2019 · Bone
Glucocorticoids and the Osteoclast
HYUN‐JU KIM, Haibo Zhao, Hideki Kitaura, Sandip Bhattacharyya, Judson A. Brewer, Louis J. Muglia, Frederick Patrick Ross, Steven L. Teitelbaum · 2007 · Annals of the New York Academy of Sciences
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era
Glenn Haugeberg, Knut Helgetveit, Øystein Førre, Torhild Garen, Hege Sommerseth, Anne Prøven · 2014 · BMC Musculoskeletal Disorders
Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction
Paul D. Miller · 2005 · Current Osteoporosis Reports
Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study
M. Amine Amiche, Shahab Abtahi, Johanna H. M. Driessen, Peter Vestergaard, Frank de Vries, Suzanne M. Cadarette, Andrea Michelle Burden · 2018 · Archives of Osteoporosis
The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials
Anne‐Birgitte Garm Blavnsfeldt, Annette Ladefoged de Thurah, Malissa Dawn Thomsen, Simon Tarp, Bente Lomholt Langdahl, Ellen‐Margrethe Hauge · 2018 · Bone
Glucocorticoids activate the local renin–angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis
Zhang Yongtao, Wang Kunzheng, Zheng Jingjing, Shan Hu, Kou Jianqiang, Liu Ruiyu, Wang Chunsheng · 2014 · Endocrine
Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus
Irene E. M. Bultink · 2017 · Calcified Tissue International
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
Gary R. Lichtenstein, Stephen B Hanauer, William J Sandborn · 2015 · Europe PMC (PubMed Central)
Bone complications in patients with Cushing’s syndrome: looking for clinical, biochemical, and genetic determinants
Laura Trementino, Gloria Appolloni, Letizia Ceccoli, Giorgia Marcelli, Carolina Concettoni, Marco Boscaro, Giorgio Arnaldi · 2013 · Osteoporosis International
Fracture, aging, and disease in bone
Joel W. Ager, Guive Balooch, Robert O. Ritchie · 2006 · Journal of materials research/Pratt's guide to venture capital sources
Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
Hansen, Karen E, Wilson, H Alexander, Zapalowski, Carol, Fink, Howard A, Minisola, Salvatore, Adler, Robert A · 2011 · Journal of Bone and Mineral Research
Bisphosphonate Fractures as a Cause of Painful Total Hip Arthroplasty
Brian M. Curtin, Thomas K. Fehring · 2011 · Orthopedics
Curcumin alleviates glucocorticoid‐induced osteoporosis by protecting osteoblasts from apoptosis in vivo and in vitro
Zhiguang Chen, Jinqi Xue, Tao Shen, Gen Ba, Dongdong Yu, Qin Fu · 2015 · Clinical and Experimental Pharmacology and Physiology
Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis
Hennie G. Raterman, Irene E. M. Bultink, Willem Frederik Lems · 2019 · Drugs
Skeletal complications of rheumatoid arthritis
Latisha D. Heinlen, Mary Beth Humphrey · 2017 · Osteoporosis International
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd Rüdiger Burmester, Yannick Palmowski, Maarten Boers et al. · 2022 · Annals of the Rheumatic Diseases
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
On behalf of ABC Group, Scillitani, A., Mazziotti, G., Di Somma, C., Moretti, S., Stigliano, A., Pivonello, R., Giustina, A., Colao, A. · 2014 · Osteoporosis International
Low-trauma fractures without osteoporosis
Éric Lespessailles, Bernard Cortet, E. Legrand, Pascal Guggenbuhl, Christian Roux · 2017 · Osteoporosis International
Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naïve postmenopausal women
Kuo-Chiang Lian, Thomas Lang, Joyce H. Keyak, Gunnard W. Modin, Qaisar Rehman, Loi Do, Nancy E. Lane · 2004 · Osteoporosis International
Osteoporosis in scleroderma
Jennifer Loucks, Janet Elizabeth Pope · 2005 · Seminars in Arthritis and Rheumatism
Bone health in multiple sclerosis
J. C. Gibson, G. D. Summers · 2011 · Osteoporosis International
Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
Marlies C. van der Goes, Johannes W. G. Jacobs, Maud S. Jurgens, Marije F. Bakker, Maaike J. van der Veen, J. H. van der Werf, Paco M J Welsing, J. W. J. Bijlsma · 2012 · Osteoporosis International
Bone alterations in inflammatory bowel diseases
Dolores Sgambato, Francesca Gimigliano, Cristiana De Musis, Antimo Moretti, Giuseppe Toro, Emanuele Ferrante, Agnese Miranda, Domenico De Mauro, Lorenzo Romano, Giovanni Iolascon et al. · 2019 · World Journal of Clinical Cases
The Threshold of Bone Mineral Density for Vertebral Fracture in Female Patients with Glucocorticoid-induced Osteoporosis
Hiroshi Kaji, Mika Yamauchi, Kazuo Chihara, Toshitsugu Sugimoto · 2006 · Endocrine Journal
Secondary osteoporosis in patients with an osteoporotic fracture
Cindy Kok, Philip N. Sambrook · 2009 · Best Practice & Research Clinical Rheumatology
Abnormalities in Cortical Bone, Trabecular Plates, and Stiffness in Postmenopausal Women Treated With Glucocorticoids
Stephanie A. Sutter, Kyle K. Nishiyama, Anna L. Kepley, Bin Zhou, Ji Wang, Donald J. McMahon, Xia Guo, Emily Margaret Stein · 2014 · The Journal of Clinical Endocrinology & Metabolism
Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity
H. Herschel Conaway, Petra Henning, Anita Lie, Jan Peter Tuckermann, Ulf H. Lerner · 2016 · Bone
Low-dose dexamethasone affects osteoblast viability by inducing autophagy via intracellular ROS
Shaokun Zhang, Yongyi Liu, Qingwei Liang · 2018 · Molecular Medicine Reports
Glucocorticoid-Induced Osteoporosis in Growing Rats
Sien Lin, Jianping Huang, Zheng Liang, Yanzhi Liu, Guihua Liu, Nan Li, Kuixing Wang, Liyi Zou, Tie Wu, Ling Qin et al. · 2014 · Calcified Tissue International
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
I A Campbell · 2004 · Thorax
Glucocorticoid-induced osteoporosis
Yasuhiro Tamura, Hiroko Okinaga, Hiroshi E. Takami · 2004 · Biomedicine & Pharmacotherapy
Should bisphosphonates be used for long‐term treatment of glucocorticoid‐induced osteoporosis?
Steven L. Teitelbaum, Margaret Seton, Kenneth G. Saag · 2010 · Arthritis & Rheumatism
Inhaled Corticosteroids and Bone Health
Carolyn Chee, Luckni Sellahewa, Joseph M Pappachan · 2015 · The Open Respiratory Medicine Journal
Drug-Induced Musculoskeletal Disorders
B Bannwarth · 2007 · Drug Safety
Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis
M. A. Amiche, Jordan M. Albaum, Mina Tadrous, Petros Pechlivanoglou, Linda E. Lévesque, Jonathan Derrick Adachi, Suzanne M. Cadarette · 2016 · Osteoporosis International
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis
Chiodini Iacopo, Alberto Falchetti, Daniela Merlotti, Eller-Vainicher Cristina, Luigi Gennari · 2020 · Expert Review of Endocrinology & Metabolism
Glucocorticoid-induced osteoporosis
Karen A. Koenig Berris, Anita Lopes Repp, Michael Kleerekoper · 2007 · Current Opinion in Endocrinology Diabetes and Obesity
Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions
Irene E. M. Bultink, Marijke Baden, Willem Frederik Lems · 2013 · Expert Opinion on Pharmacotherapy
Advances in treatment of glucocorticoid-induced osteoporosis
Emory Hsu, Mark S. Nanes · 2017 · Current Opinion in Endocrinology Diabetes and Obesity
Mineral and Bone Disorders After Kidney Transplantation
Chandan Vangala, Jenny Szu-Chin Pan, Ronald Timothy Cotton, Venkat Ramanathan · 2018 · Frontiers in Medicine
Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis
Jason A. Inzana, Jason R. Maher, Masahiko Takahata, Edward M. Schwarz, Andrew J. Berger, Hani A. Awad · 2012 · Journal of Biomechanics
Glucocorticoid-induced osteoporosis
Silverman, Stuart L., Lane, Nancy E. · 2009 · Current Osteoporosis Reports
Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case–control study using HR-pQCT
Xiao Tang, Ling Qin, Anthony Wai Leung Kwok, TRACY YANER ZHU, Emily Wai Lin Kun, Vivian Wing-Yin Hung, James Francis Griffith, Ping‐Chung Leung, Edmund K. Li, Lai‐Shan Tam · 2012 · Osteoporosis International
Lupus and fractures
Irene E. M. Bultink, Willem Frederik Lems · 2016 · Current Opinion in Rheumatology
Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures
Margaret L. Gourlay, Nora Franceschini, Yevgeniy Sheyn · 2006 · Clinical Rheumatology
Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society
Julien Paccou, Maria P. Yavropoulou, Anda Mihaela Naciu, Manju Chandran, Osvaldo Daniel Messina, Tim Rolvien, JOHN J. CAREY, Stella D’Oronzo, Athanasios D. Anastasilakis, Kenneth G. Saag et al. · 2024 · European Journal of Endocrinology
The temporal characterization of marrow lipids and adipocytes in a rabbit model of glucocorticoid-induced osteoporosis
Guanwu Li, Zheng Xu, Qi‐Wen Chen, Shixin Chang, Yanan Tian, Jingzheng Fan · 2013 · Skeletal Radiology
Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis
Thawee Songpatanasilp, Chanika Sritara, Wasuwat Kitisomprayoonkul, S. Chaiumnuay, Hataikarn Nimitphong, Natthinee Charatcharoenwitthaya, Chatlert Pongchaiyakul, S. Namwongphrom, Tasanee Kitumnuaypong, W. Srikam et al. · 2016 · Osteoporosis and Sarcopenia
Glucocorticoid Excess in Bone and Muscle
Amy Y. Sato, Munro Peacock, Teresita Bellido · 2018 · Clinical Reviews in Bone and Mineral Metabolism
Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation
Jung Min Hong, Steven L. Teitelbaum, Taeho Kim, Frederick Patrick Ross, Shin‐Yoon Kim, Hyun‐Ju Kim · 2010 · Journal of Bone and Mineral Research
Long-term therapy in COPD: any evidence of adverse effect on bone?
Arnulf Langhammer · 2009 · International Journal of COPD
NOFSA Guideline for the Diagnosis and Management of Osteoporosis
Stephen F. Hough, Brynne H. Ascott-Evans, Susan L Brown, Bilkish Cassim, Tobie J. de Villiers, Stan Lipschitz, John Morley Pettifor, Ernst W.W. Sonnendecker · 2010 · Journal of Endocrinology Metabolism and Diabetes of South Africa
Vertebral strength changes in rheumatoid arthritis patients treated with alendronate, as assessed by finite element analysis of clinical computed tomography scans: A prospective randomized clinical trial
Taro Mawatari, Hiromasa Miura, Satoshi Hamai, Toshihide Shuto, Yasuharu Nakashima, Ken Okazaki, Naoko Kinukawa, Shuji Sakai, Paul F. Hoffmann, Yukihide Iwamoto et al. · 2008 · Arthritis & Rheumatism
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy
Béatrice Bouvard, E. Hoppé, P Soulié, M. Georgin-Mège, Eric Jadaud, Sophie Abadie‐Lacourtoisie, Audrey Petit Le Manac’h, A. Laffitte, Régis Levasseur, Maurice Audran et al. · 2011 · Annals of Oncology
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
Tjeerd Pieter van Staa, Piet Geusens, B. Zhang, Hubert G. M. Leufkens, Annelies E. R. C. H. Boonen, Cyrus C. Cooper · 2006 · Rheumatology
Trabecular Bone Score Reflects Trabecular Microarchitecture Deterioration and Fragility Fracture in Female Adult Patients Receiving Glucocorticoid Therapy: A Pre-Post Controlled Study
Mei‐Hua Chuang, Tzyy‐Ling Chuang, Malcolm Koo, Yuh‐Feng Wang · 2017 · BioMed Research International
Effects of Medical Treatment of Prostate Cancer on Bone Health
Anna Maria Formenti, Alberto Dalla Volta, Luigi di Filippo, Alfredo Berruti, Andrea Giustina · 2021 · Trends in Endocrinology and Metabolism
The management of secondary osteoporosis
Ariella Kelman, Nancy E. Lane · 2005 · Best Practice & Research Clinical Rheumatology
Bisphosphonates pharmacology and use in the treatment of osteoporosis
Dima L. Diab, Nelson B. Watts, Paul D. Miller · 2020 · Elsevier eBooks
Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature
Gaetano Caramori, Paolo Ruggeri, Fabio Arpinelli, Laura Salvi, Giuseppe Girbino · 2019 · International Journal of COPD
Risk Factors and Management of Osteoporosis Post-Transplant
Karthik Reddy Kovvuru, Swetha Rani Kanduri, Pradeep K. Vaitla, Rachana Marathi, Shiva Kumar Gosi, Desiree Garcia Anton, Franco H. Cabeza Rivera, Vishnu Vardhan Garla · 2020 · Medicina
ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease
Francis A. Farraye, Gil Melmed, Gary R. Lichtenstein, Edward L. Barnes, Berkeley N. Limketkai, Freddy Caldera, Sunanda V. Kane · 2025 · The American Journal of Gastroenterology
Glucocorticoid‐induced bone fragility
Nancy E. Lane, Wei Yao · 2010 · Annals of the New York Academy of Sciences
Spontaneous recovery of bone mass after cure of endogenous hypercortisolism
Maria Elena Randazzo, Erika Maria Grossrubatscher, Paolo Dalino Ciaramella, Angelo Vanzulli, Paola Loli · 2011 · Pituitary
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study
Maurizio Rossini, Ombretta Viapiana, Maria Vitiello, Nazzarena Malavolta, GIOVANNI LA MONTAGNA, Susanna Maddali Bongi, Ombretta Di Munno, Ranuccio Nuti, C. U. Manzini, C. Ferri et al. · 2017 · Reumatismo
Autophagy relieves the function inhibition and apoptosis‑promoting effects on osteoblast induced by glucocorticoid
Yan Han, Lihai Zhang, Yaling Xing, Licheng Zhang, Xiaojuan Chen, Peifu Tang, Zhongbin Chen · 2017 · International Journal of Molecular Medicine
Treatment options for glucocorticoid-induced osteoporosis
Iacopo Chiodini, Daniela Merlotti, Alberto Falchetti, Luigi Gennari · 2020 · Expert Opinion on Pharmacotherapy
Update on Glucocorticoid-Induced Osteoporosis
Michael J. Maricic · 2011 · Rheumatic Disease Clinics of North America
Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits
Xuli Liu, Wei Lei, Zixiang Wu, Yi Cui, Bao-jun Han, Suochao Fu, Changli Jiang · 2011 · Medical Engineering & Physics
Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis
Tsuyoshi Sugiura, Masafumi Kashii, Yohei Matsuo, Tokimitsu Morimoto, Hirotsugu Honda, Takashi Kaito, Motoki Iwasaki, Hideki Yoshikawa · 2014 · The Spine Journal
Glucocorticoid induced osteoporosis
Kira Hu, Jonathan Derrick Adachi · 2019 · Expert Review of Endocrinology & Metabolism
Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression
Claudia Mendoza Pinto, Adriana Rojas‐Villarraga, Nicolás Molano‐González, Erick Alejandro Jiménez-Herrera, María de la Luz León Vázquez, Álvaro José Montiel-Jarquín, Mario García‐Carrasco, Ricard Cervera · 2018 · PLoS ONE
Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
So Young Park, Hyun Sik Gong, Kyoung Min Kim, Dam Kim, Ha Young Kim, Chan Hong Jeon, Ji Hyeon Ju, Shin‐Seok Lee, Dong Ah Park, Yoon‐Kyoung Sung et al. · 2018 · Journal of Bone Metabolism
Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease
Stefano Frara, Agnese Allora, Luigi di Filippo, Anna Maria Formenti, Paola Loli, Elisabetta Polizzi, Daniele Tradati, Fabio Massimo Ulivieri, Andrea Giustina · 2021 · Best Practice & Research Clinical Endocrinology & Metabolism
Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis
Angelo Karunaratne, L. Xi, Liz Bentley, Dan Sykes, ALAN BOYDE, Christopher T. Esapa, Nicholas J. Terrill, Steve D. M. Brown, Roger Cox, Rajesh V. Thakker et al. · 2015 · Bone
Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy
on behalf of the GHDP study group, María Luz Rentero, Encarna Amigo, Nicolás Chozas, Manuel Fernández Prada, Lucía Silva-Fernández, Miguel Ángel Abad Hernández, Jose Maria Rodriguez Barrera, Javier del Pino‐Montes · 2015 · BMC Musculoskeletal Disorders
The Skeletal Effects of Inhaled Glucocorticoids
Stephanie A. Sutter, Emily Margaret Stein · 2016 · Current Osteoporosis Reports
Fractal and radiomorphometric analysis of mandibular bone changes in patients undergoing intravenous corticosteroid therapy
Ceren Aktuna Belgın, Gözde Serindere · 2020 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
Glucocorticoid-Induced Osteoporosis: Mechanisms and Therapeutic Approach
Jean‐Pierre Devogelaer · 2006 · Rheumatic Disease Clinics of North America
Systemic lupus erythematosus and fractures
Irene E. M. Bultink, Willem Frederik Lems · 2015 · RMD Open
Ten Common Mistakes in the Management of Lupus Nephritis
Bhadran Bose, Earl D. Silverman, Joanne M. Bargman · 2013 · American Journal of Kidney Diseases
TSH suppressive therapy and bone
Alessandro Brancatella, Claudio Marcocci · 2020 · Endocrine Connections
Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study
Julia Spoendlin, Christian Meier, Susan S. Jick, Christoph Rudolf Meier · 2015 · Annals of Medicine
Management of osteoporosis in a pre-menopausal woman
Ashok K. Bhalla · 2010 · Best Practice & Research Clinical Rheumatology
Cushing's syndrome and bone mineral density: lowest Z scores in young patients.
Anke W. van der Eerden, Martin den Heijer, Wim J.G. Oyen, A. R. M. M. Hermus · 2007 · PubMed
Non-invasive Techniques for Bone Mass Measurement
Mary Beth Leonard, Laura K. Bachrach · 2011 · Elsevier eBooks
Methotrexate, Azathioprine, Cyclosporine, and Risk of Fracture
Poul Frølund Vestergaard, Lars Rejnmark, Leif Mosekilde · 2006 · Calcified Tissue International
Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment
Albrecht Werner Popp, Juerg Isenegger, Elizabeth M. Buergi, Ulrich Buergi, Kurt Lippuner · 2006 · European Spine Journal
Standards for Performing DXA in Individuals With Secondary Causes of Osteoporosis
Aliya Aziz Khan, David A. Hanley, John Paul Bilezikian, Neil Binkley, Jacques P. Brown, Anthony B. Hodsman, Robert G. Josse, David L. Kendler, Edward Michael Lewiecki, Paul D. Miller et al. · 2006 · Journal of Clinical Densitometry
Drugs Causing Bone Loss
Peter Vestergaard · 2019 · Handbook of experimental pharmacology
Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats
R H Nielsen, Claus Christiansen, Marina Stolina, M.A. Karsdal · 2008 · Clinical & Experimental Immunology
Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis.
Mubin I. Syed, Neel A Patel, Shanzay Jan, A. Shaikh, Beverly K. Grunden, Kamal Morar · 2006 · PubMed Central